These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1176 related items for PubMed ID: 9973433

  • 1. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 2. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP.
    J Immunol; 1999 Feb 15; 162(4):2358-67. PubMed ID: 9973516
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug 15; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 5. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.
    Delgado M, Sun W, Leceta J, Ganea D.
    J Immunol; 1999 Oct 15; 163(8):4213-23. PubMed ID: 10510358
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C, Delgado M, Gomariz RP, Ganea D.
    J Immunol; 1996 Jun 01; 156(11):4128-36. PubMed ID: 8666779
    [Abstract] [Full Text] [Related]

  • 7. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP.
    Ganea D, Delgado M.
    Arch Immunol Ther Exp (Warsz); 2001 Jun 01; 49(2):101-10. PubMed ID: 11348014
    [Abstract] [Full Text] [Related]

  • 8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia.
    Delgado M.
    Biochem Biophys Res Commun; 2002 May 03; 293(2):771-6. PubMed ID: 12054537
    [Abstract] [Full Text] [Related]

  • 9. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M, Reduta A, Sharma V, Ganea D.
    J Leukoc Biol; 2004 Jun 03; 75(6):1122-30. PubMed ID: 15020654
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun 03; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo.
    Delgado M, Ganea D.
    J Immunol; 2001 Jul 15; 167(2):966-75. PubMed ID: 11441105
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
    Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP.
    J Immunol; 1999 Jan 15; 162(2):1200-5. PubMed ID: 9916753
    [Abstract] [Full Text] [Related]

  • 13. Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide.
    Delgado M, Leceta J, Abad C, Martinez C, Ganea D, Gomariz RP.
    J Neuroimmunol; 1999 Sep 01; 99(1):61-71. PubMed ID: 10496178
    [Abstract] [Full Text] [Related]

  • 14. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
    Taupenot L, Mahata SK, Wu H, O'Connor DT.
    J Clin Invest; 1998 Feb 15; 101(4):863-76. PubMed ID: 9466982
    [Abstract] [Full Text] [Related]

  • 15. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
    Leceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M.
    Ann N Y Acad Sci; 2000 Feb 15; 921():92-102. PubMed ID: 11193883
    [Abstract] [Full Text] [Related]

  • 16. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor.
    Soares MB, Titus RG, Shoemaker CB, David JR, Bozza M.
    J Immunol; 1998 Feb 15; 160(4):1811-6. PubMed ID: 9469441
    [Abstract] [Full Text] [Related]

  • 17. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug 15; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 18. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Neuroimmunol; 1999 May 03; 96(2):167-81. PubMed ID: 10337915
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophages.
    Sun W, Tadmori I, Yang L, Delgado M, Ganea D.
    J Neuroimmunol; 2000 Jul 10; 107(1):88-99. PubMed ID: 10808055
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar 10; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.